Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Public disagrees with doctors on when it's right to withhold treatment

15.02.2008
Doctors do not think like the general public when it comes to making decisions about how to treat – or not treat – severely ill patients. According to research published in the open access journal Critical Care, the majority of doctors would withhold treatment in certain circumstances, whereas most members of the public would not.

Researchers in Sweden sent a questionnaire to almost 1000 adults randomly selected from the general population, and more than 400 intensive care doctors and neurosurgeons. In plain language, it worked through the case of a 72-year-old patient suffering from a severe intracerebral haemorrhage.

First, it looked at the case for and against neurosurgery. Second, it considered what should be done when, following the operation, it became clear that the patient would not survive without life support. Finally, after life support had been withdrawn, it asked whether potent sedatives and analgesics should be administered, even though this might hasten death.

The majority of the public (59.8%) supported arguments in favour of performing the neurosurgery, saying that “the primary task of health care is to save lives”. Most of the doctors (82.3%), however, were reluctant to perform heroic surgery in the setting of a pessimistic prognosis, arguing that surgery would not improve the patient's quality of life.

Neither of the groups was swayed by the age of the patient or cost-benefit argument for not performing surgery.

As the patient’s health deteriorated, the study demonstrates that the attitudes of the public and doctors begin to converge. A majority of doctors and the public supported the withdrawal of life support, although often for different reasons. More of the public considered the patient's wishes to be important.

Over 95% of doctors and 82% of the public agreed to the administration of potent sedatives and analgesics, both groups wanting to keep the patient calm and pain-free rather than hasten death. More members of the public than doctors said that drugs should not be given if there was any risk of hastening death; over a quarter of the public regarded this as a form of euthanasia rather than an inevitable side effect.

“On the whole, the results indicate that the general public has high expectations of what the health care system is capable of doing,” notes Anders Rydvall, who led the study. “It is important that doctors appreciate the differences in the ways that they and the public work through these difficult decisions. If they understand the arguments, expectations and preferences of the public or relatives that will be better equipped to prevent miscommunication or controversy.”

Charlotte Webber | alfa
Further information:
http://www.biomedcentral.com

More articles from Studies and Analyses:

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Disarray in the brain
18.12.2017 | Universität zu Lübeck

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>